Tandem duplication PCR: An ultrasensitive assay for the detection of internal tandem duplications of the FLT3 Gene

Diagnostic Molecular Pathology

Volumn 22, Issue 3, 2013, Pages 149-155

  Lin, Ming Tseh ^a   Tseng, Li Hui ^a   Beierl, Katie ^a   Hsieh, Antony ^a   Thiess, Michele ^a   Chase, Nadine ^a   Stafford, Amanda ^a   Levis, Mark J ^b   Eshleman, James R ^a,b   Gocke, Christopher D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

acute myeloid leukemia; FLT3; internal tandem duplication; minimal residual disease; tandem duplication PCR

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; FLT3 GENE; GENE; GENE DUPLICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TANDEM REPEAT;

EID: 84883465084     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/PDM.0b013e31828308a1     Document Type: Article

References (15)

1. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411:355-365. (Pubitemid 32467045)
2. Turner AM, Lin NL, Issarachai S, et al. FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells. Blood. 1996;88:3383-3390. (Pubitemid 26365572)
3. Kottaridis PD, Gale RE, Frew ME, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom medical research council AML 10 and 12 trials. Blood. 2001;98:1752-1759.
4. Meshinchi S, Woods WG, Stirewalt DL, et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood. 2001;97:89-94. (Pubitemid 32061246)
5. Thiede C, Steudel C, Mohr B, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood. 2002;99:4326-4335. (Pubitemid 34627197)
6. Schnittger S, Schoch C, Dugas M, et al. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood. 2002;100:59-66. (Pubitemid 35177429)
7. Schnittger S, Schoch C, Kern W, et al. FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia. Acta Haematol. 2004;112:68-78. (Pubitemid 38716251)
8. Stirewalt DL, Willman CL, Radich JP. Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific. Leuk Res. 2001;25:1085-1088. (Pubitemid 33000489)
9. Nakao M, Yokota S, Iwai T, et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia. 1996;10:1911-1918. (Pubitemid 27019637)
10. Murphy KM, Levis M, Hafez MJ, et al. Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay. J Mol Diagn. 2003;5:96-102. (Pubitemid 36553429)
11. Beierl K, Tseng LH, Beierl R, et al. Detection of minor clones with internal tandem duplication mutations of FLT3 gene in acute myeloid leukemia using delta-PCR. Diagn Mol Pathol. 2012. (In press).
12. Lam KW, Jeffreys AJ. Processes of de novo duplication of human alpha-globin genes. Proc Natl Acad Sci USA. 2007;104:10950-10955. (Pubitemid 47175207)
13. Lin MT, Tseng LH, Rich RG, et al. D-PCR, a simple method to detect translocations and insertion/deletion mutations. J Mol Diagn. 2011;13:85-92.
14. Lin MT, Rich RG, Shipley RF, et al. A molecular fraction collecting tool for the ABI 310 automated sequencer. J Mol Diagn. 2007; 9:598-603. (Pubitemid 350158418)
15. Shih LY, Huang CF, Wu JH, et al. Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. Blood. 2002;100:2387-2392.